Can I take fenelide without diabetic nephropathy?

Finerenone (Finerenone) is indicated to reduce the risk of persistent decline in estimated glomerular filtration rate (eGFR), end-stage renal disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes. The American Diabetes Association and Kidney Disease Guidelines: Improving Global Outcomes recommend the use of fenelidone in patients with type 2 diabetes and CKD who are at high risk for CKD progression and cardiovascular events despite use of recommended treatments.

According to existing research and clinical practice, fenelidone is mainly suitable for patients with type 2 diabetes and chronic kidney disease accompanied by albuminuria. For patients without diabetic nephropathy, the applicability of fenelidone requires further study and exploration. Although fenelidone has shown good efficacy in treating diabetic nephropathy, it also has certain side effects and risks. Common side effects include hyperkalemia, hypernatremia, hypotension, allergies, kidney damage, etc. Prolonged use of fenelidone may also cause damage to kidney function and affect normal urination. Therefore, use of fenelidone in the absence of clear indications may increase unnecessary risks.

Hyperkalemia may occur in patients who take an overdose of fenelinone. Even if there is an overdose, fenelidone should be stopped immediately. Treat patients symptomatically and supportively, including treatment of hyperkalemia if present. Because of the high plasma protein binding of fenelidone, hemodialysis is not expected to clear fenelidone from the blood.

In summary, for patients without diabetic nephropathy, whether they can take fenelidone needs to be carefully considered. In the absence of clear indications, discretionary use of fenelidone is not recommended. If it is really necessary to use this drug, it should be done under the guidance of a doctor, and regular follow-up visits should be carried out to detect changes in blood potassium, renal function and other indicators to ensure the effectiveness and safety of the treatment.